NM6603
/ NucMito Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 12, 2025
A Phase 1 Study of NM6603 in Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: NucMito Pharmaceuticals Co. Ltd. | Trial completion date: Jul 2026 ➔ Feb 2026 | Trial primary completion date: Feb 2026 ➔ Oct 2025
Trial completion date • Trial primary completion date • Oncology • Solid Tumor
September 21, 2023
A Phase 1 Study of NM6603 in Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: NucMito Pharmaceuticals Co. Ltd.
Metastases • New P1 trial • Gastrointestinal Cancer • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1